Stay updated on Pegilodecakin Combo vs Pembrolizumab Alone in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pegilodecakin Combo vs Pembrolizumab Alone in NSCLC Clinical Trial page.

Latest updates to the Pegilodecakin Combo vs Pembrolizumab Alone in NSCLC Clinical Trial page
- Check2 days agoChange DetectedThe page now shows a recruitment closure note ('No longer looking for participants'), and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). The Study Details heading formatting changes from 'Intervention / Treatment' to 'Intervention/Treatment' to reflect a consistency update.SummaryDifference0.3%

- Check9 days agoChange DetectedThe page revision tag was updated from v3.5.4 to v3.5.5, indicating a minor site build version bump.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4. This represents a minor update to the page's revision history rather than a substantive content change.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page footer revision marker was updated to **Revision: v3.5.3** (from **v3.5.2**), reflecting an interface/version change rather than any study-record information.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check89 days agoChange Detected- Revision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.0%

Stay in the know with updates to Pegilodecakin Combo vs Pembrolizumab Alone in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pegilodecakin Combo vs Pembrolizumab Alone in NSCLC Clinical Trial page.